Difference between revisions of "Template:Chemotherapeutic agents"

From blackwiki
Jump to navigation Jump to search
imported>Anypodetos
imported>Anypodetos
m (Simplify markup, replaced:  • →  • (46), <BR> → <br /> (7) using AWB)
Line 5: Line 5:
 
| groupstyle = background-color: #E5BFE5
 
| groupstyle = background-color: #E5BFE5
  
   | group1 = [[Spindle poison|SP]]s/[[mitotic inhibitor|MI]]s<BR>([[M phase]])
+
   | group1 = [[Spindle poison|SP]]s/[[mitotic inhibitor|MI]]s<br />([[M phase]])
 
   |  list1 = {{Navbox subgroup
 
   |  list1 = {{Navbox subgroup
 
| groupstyle = background-color: #E5BFE5
 
| groupstyle = background-color: #E5BFE5
Line 13: Line 13:
  
 
| group2 = Block microtubule disassembly
 
| group2 = Block microtubule disassembly
| list2  = ''[[Taxane]]s'' ([[Cabazitaxel]], [[Docetaxel]], [[Larotaxel]], [[Ortataxel]], [[Paclitaxel]], [[Tesetaxel]])&#160;&#8226;  ''[[Epothilone]]s'' ([[Ixabepilone]])
+
| list2  = ''[[Taxane]]s'' ([[Cabazitaxel]], [[Docetaxel]], [[Larotaxel]], [[Ortataxel]], [[Paclitaxel]], [[Tesetaxel]])&nbsp; ''[[Epothilone]]s'' ([[Ixabepilone]])
  
 
}}
 
}}
  
   | group2 = [[DNA replication]]<BR>inhibitor
+
   | group2 = [[DNA replication]]<br />inhibitor
 
   |  list2 = {{Navbox subgroup
 
   |  list2 = {{Navbox subgroup
 
   | groupstyle = background-color: #E5BFE5
 
   | groupstyle = background-color: #E5BFE5
  
| group1 = DNA precursors/<BR>[[antimetabolite]]s<BR>([[S phase]])
+
| group1 = DNA precursors/<br />[[antimetabolite]]s<br />([[S phase]])
 
|  list1 = {{Navbox subgroup
 
|  list1 = {{Navbox subgroup
 
   | groupstyle = background-color: #E5BFE5
 
   | groupstyle = background-color: #E5BFE5
Line 27: Line 27:
  
 
| group1 = [[Antifolate|Folic acid]]
 
| group1 = [[Antifolate|Folic acid]]
| list1  = ''[[dihydrofolate reductase inhibitor]]'' ([[Aminopterin]], [[Methotrexate]], [[Pemetrexed]], [[Pralatrexate]])&#160;&#8226;  ''[[thymidylate synthase inhibitor]]'' ([[Raltitrexed]], [[Pemetrexed]])
+
| list1  = ''[[dihydrofolate reductase inhibitor]]'' ([[Aminopterin]], [[Methotrexate]], [[Pemetrexed]], [[Pralatrexate]])&nbsp; ''[[thymidylate synthase inhibitor]]'' ([[Raltitrexed]], [[Pemetrexed]])
  
 
| group2 = [[Purine analogue|Purine]]
 
| group2 = [[Purine analogue|Purine]]
 
| list2  = ''[[adenosine deaminase inhibitor]]'' ([[Pentostatin]])
 
| list2  = ''[[adenosine deaminase inhibitor]]'' ([[Pentostatin]])
  
''[[halogenated]]/[[ribonucleotide reductase inhibitor]]s'' ([[Cladribine]], [[Clofarabine]], [[Fludarabine]])<BR>
+
''[[halogenated]]/[[ribonucleotide reductase inhibitor]]s'' ([[Cladribine]], [[Clofarabine]], [[Fludarabine]])<br />
  
 
''[[thiopurine]]'' ([[Tioguanine|Thioguanine]], [[Mercaptopurine]])
 
''[[thiopurine]]'' ([[Tioguanine|Thioguanine]], [[Mercaptopurine]])
Line 50: Line 50:
 
}}
 
}}
  
| group2 = [[Topoisomerase inhibitor]]s<BR>([[S phase]])
+
| group2 = [[Topoisomerase inhibitor]]s<br />([[S phase]])
 
| list2  = {{Navbox subgroup
 
| list2  = {{Navbox subgroup
 
| groupstyle = background-color: #E5BFE5
 
| groupstyle = background-color: #E5BFE5
Line 61: Line 61:
  
 
| group3 = [[Topoisomerase_II#Inhibition|II]]+[[Intercalation (chemistry)|Intercalation]]
 
| group3 = [[Topoisomerase_II#Inhibition|II]]+[[Intercalation (chemistry)|Intercalation]]
| list3  = ''[[Anthracycline]]s'' ([[Aclarubicin]], [[Daunorubicin]], [[Doxorubicin]], [[Epirubicin]], [[Idarubicin]], [[Amrubicin]], [[Pirarubicin]], [[Valrubicin]], [[Zorubicin]])&#160;&#8226;  ''[[Anthracenedione]]s'' ([[Mitoxantrone]], [[Pixantrone]])
+
| list3  = ''[[Anthracycline]]s'' ([[Aclarubicin]], [[Daunorubicin]], [[Doxorubicin]], [[Epirubicin]], [[Idarubicin]], [[Amrubicin]], [[Pirarubicin]], [[Valrubicin]], [[Zorubicin]])&nbsp; ''[[Anthracenedione]]s'' ([[Mitoxantrone]], [[Pixantrone]])
  
 
}}
 
}}
  
  
   | group3 = [[Crosslinking of DNA]]<BR>([[cell-cycle nonspecific antineoplastic agents|CCNS]])
+
   | group3 = [[Crosslinking of DNA]]<br />([[cell-cycle nonspecific antineoplastic agents|CCNS]])
 
   |  list3 = {{Navbox subgroup
 
   |  list3 = {{Navbox subgroup
 
| groupstyle = background-color: #E5BFE5
 
| groupstyle = background-color: #E5BFE5
  
 
| group1 = [[Alkylating antineoplastic agent|Alkylating]]
 
| group1 = [[Alkylating antineoplastic agent|Alkylating]]
| list1  = ''[[Nitrogen mustard]]s:'' [[Mechlorethamine]]&#160;&#8226;  [[Cyclophosphamide]] ([[Ifosfamide]], [[Trofosfamide]])&#160;&#8226;  [[Chlorambucil]] ([[Melphalan]], [[Prednimustine]])&#160;&#8226;  [[Bendamustine]]&#160;&#8226;  [[Uramustine]]&#160;&#8226;  [[Estramustine]]
+
| list1  = ''[[Nitrogen mustard]]s:'' [[Mechlorethamine]]&nbsp; [[Cyclophosphamide]] ([[Ifosfamide]], [[Trofosfamide]])&nbsp; [[Chlorambucil]] ([[Melphalan]], [[Prednimustine]])&nbsp; [[Bendamustine]]&nbsp; [[Uramustine]]&nbsp; [[Estramustine]]
  
''[[Nitrosourea]]s:'' [[Carmustine]]&#160;&#8226;  [[Lomustine]] ([[Semustine]])&#160;&#8226;  [[Fotemustine]]&#160;&#8226;  [[Nimustine]]&#160;&#8226;  [[Ranimustine]]&#160;&#8226;  [[Streptozotocin|Streptozocin]]
+
''[[Nitrosourea]]s:'' [[Carmustine]]&nbsp; [[Lomustine]] ([[Semustine]])&nbsp; [[Fotemustine]]&nbsp; [[Nimustine]]&nbsp; [[Ranimustine]]&nbsp; [[Streptozotocin|Streptozocin]]
  
 
''[[Alkyl sulfonate]]s:'' [[Busulfan]] ([[Mannosulfan]], [[Treosulfan]])
 
''[[Alkyl sulfonate]]s:'' [[Busulfan]] ([[Mannosulfan]], [[Treosulfan]])
  
''[[Aziridine]]s:'' [[Carboquone]]&#160;&#8226;  [[ThioTEPA]]&#160;&#8226;  [[Triaziquone]]&#160;&#8226;  [[Triethylenemelamine]]
+
''[[Aziridine]]s:'' [[Carboquone]]&nbsp; [[ThioTEPA]]&nbsp; [[Triaziquone]]&nbsp; [[Triethylenemelamine]]
  
 
| group2 = [[Alkylating_antineoplastic_agent#Alkylating-like|Alkylating-like]]
 
| group2 = [[Alkylating_antineoplastic_agent#Alkylating-like|Alkylating-like]]
Line 83: Line 83:
  
 
|group3  = [[Alkylating_antineoplastic_agent#Nonclassical|Nonclassical]]
 
|group3  = [[Alkylating_antineoplastic_agent#Nonclassical|Nonclassical]]
|list3  =  ''[[Hydrazine]]s'' ([[Procarbazine]])&#160;&#8226;  ''[[Triazene]]s'' ([[Dacarbazine]], [[Temozolomide]])&#160;&#8226;  [[Altretamine]]&#160;&#8226;  [[Mitobronitol]]
+
|list3  =  ''[[Hydrazine]]s'' ([[Procarbazine]])&nbsp; ''[[Triazene]]s'' ([[Dacarbazine]], [[Temozolomide]])&nbsp; [[Altretamine]]&nbsp; [[Mitobronitol]]
  
 
|group4  = [[Intercalation (chemistry)|Intercalation]]
 
|group4  = [[Intercalation (chemistry)|Intercalation]]
Line 94: Line 94:
  
 
   | group4 = [[Photosensitizer]]s/[[Photodynamic therapy|PDT]]
 
   | group4 = [[Photosensitizer]]s/[[Photodynamic therapy|PDT]]
   |  list4 = [[D-Aminolevulinic acid|Aminolevulinic acid]]/[[Methyl aminolevulinate]]&#160;&#8226;  [[Efaproxiral]]&#160;&#8226;  ''[[Porphyrin|Porphyrin derivatives]]'' ([[Porfimer sodium]], [[Talaporfin]], [[Temoporfin]], [[Verteporfin]])
+
   |  list4 = [[D-Aminolevulinic acid|Aminolevulinic acid]]/[[Methyl aminolevulinate]]&nbsp; [[Efaproxiral]]&nbsp; ''[[Porphyrin|Porphyrin derivatives]]'' ([[Porfimer sodium]], [[Talaporfin]], [[Temoporfin]], [[Verteporfin]])
  
 
   | group5 = Other
 
   | group5 = Other
Line 101: Line 101:
  
 
| group1 = [[Enzyme inhibitor]]s
 
| group1 = [[Enzyme inhibitor]]s
| list1  = ''[[Farnesyltransferase inhibitor|FI]]'' ([[Tipifarnib]]) &#160;&#8226;  ''[[cyclin-dependent kinase|CDK]] [[Protein kinase inhibitor|inhibitor]]s'' ([[Alvocidib]], [[Seliciclib]])&#160;&#8226;  ''[[Proteasome inhibitor|PrI]]'' ([[Bortezomib]])&#160;&#8226;  ''[[Phosphodiesterase inhibitor|PhI]]'' ([[Anagrelide]])&#160;&#8226;  ''[[IMP dehydrogenase|IMPDI]]'' ([[Tiazofurine]])&#160;&#8226;  ''[[Lipoxygenase inhibitor|LI]]'' ([[Masoprocol]])&#160;&#8226;  ''[[PARP inhibitor]]'' ([[Olaparib]])&#160;&#8226;  ''[[Histone deacetylase inhibitor|HDAC]]'' ([[Vorinostat]], [[Romidepsin]])
+
| list1  = ''[[Farnesyltransferase inhibitor|FI]]'' ([[Tipifarnib]]) &nbsp; ''[[cyclin-dependent kinase|CDK]] [[Protein kinase inhibitor|inhibitor]]s'' ([[Alvocidib]], [[Seliciclib]])&nbsp; ''[[Proteasome inhibitor|PrI]]'' ([[Bortezomib]])&nbsp; ''[[Phosphodiesterase inhibitor|PhI]]'' ([[Anagrelide]])&nbsp; ''[[IMP dehydrogenase|IMPDI]]'' ([[Tiazofurine]])&nbsp; ''[[Lipoxygenase inhibitor|LI]]'' ([[Masoprocol]])&nbsp; ''[[PARP inhibitor]]'' ([[Olaparib]])&nbsp; ''[[Histone deacetylase inhibitor|HDAC]]'' ([[Vorinostat]], [[Romidepsin]])
  
 
| group2 = [[Receptor antagonist]]s
 
| group2 = [[Receptor antagonist]]s
| list2  = ''[[Endothelin receptor antagonist|ERA]]'' ([[Atrasentan]])&#160;&#8226;  ''[[retinoid X receptor]]'' ([[Bexarotene]])&#160;&#8226;  ''[[sex steroid]]'' ([[Testolactone]])
+
| list2  = ''[[Endothelin receptor antagonist|ERA]]'' ([[Atrasentan]])&nbsp; ''[[retinoid X receptor]]'' ([[Bexarotene]])&nbsp; ''[[sex steroid]]'' ([[Testolactone]])
  
 
|group3  = Other/ungrouped
 
|group3  = Other/ungrouped
|list3  = [[Amsacrine]]&#160;&#8226;  [[Trabectedin]]&#160;&#8226;  ''[[retinoid]]s'' ([[Alitretinoin]], [[Tretinoin]])&#160;&#8226;  [[Arsenic trioxide]]&#160;&#8226;  ''[[Asparagine|asparagine depleter]]s'' ([[Asparaginase]]/[[Pegaspargase]])&#160;&#8226;  [[Celecoxib]]&#160;&#8226;  [[Demecolcine]]&#160;&#8226;  [[Elesclomol]]&#160;&#8226;  [[Elsamitrucin]]&#160;&#8226;  [[Etoglucid]]&#160;&#8226;  [[Lonidamine]]&#160;&#8226;  [[Lucanthone]]&#160;&#8226;  [[Mitoguazone]]&#160;&#8226;  [[Mitotane]]&#160;&#8226;  [[Oblimersen]]&#160;&#8226; [[Omacetaxine mepesuccinate]]&#160;&#8226; ''[[mTOR inhibitor]]s'' ([[Everolimus]], [[Temsirolimus]])
+
|list3  = [[Amsacrine]]&nbsp; [[Trabectedin]]&nbsp; ''[[retinoid]]s'' ([[Alitretinoin]], [[Tretinoin]])&nbsp; [[Arsenic trioxide]]&nbsp; ''[[Asparagine|asparagine depleter]]s'' ([[Asparaginase]]/[[Pegaspargase]])&nbsp; [[Celecoxib]]&nbsp; [[Demecolcine]]&nbsp; [[Elesclomol]]&nbsp; [[Elsamitrucin]]&nbsp; [[Etoglucid]]&nbsp; [[Lonidamine]]&nbsp; [[Lucanthone]]&nbsp; [[Mitoguazone]]&nbsp; [[Mitotane]]&nbsp; [[Oblimersen]]&nbsp;[[Omacetaxine mepesuccinate]]&nbsp;''[[mTOR inhibitor]]s'' ([[Everolimus]], [[Temsirolimus]])
 
}}
 
}}
  

Revision as of 09:12, 3 January 2011